The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System decreased its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 9.7% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 164,879 shares of the medical device company’s stock after selling 17,685 shares during the quarter. New York State Teachers Retirement System’s holdings in Cooper Companies were worth $13,908,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of COO. Amalgamated Bank grew its position in Cooper Companies by 1.6% in the 1st quarter. Amalgamated Bank now owns 38,686 shares of the medical device company’s stock valued at $3,263,000 after buying an additional 597 shares in the last quarter. KBC Group NV lifted its stake in shares of Cooper Companies by 1.2% in the 1st quarter. KBC Group NV now owns 251,968 shares of the medical device company’s stock worth $21,253,000 after acquiring an additional 3,045 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Cooper Companies by 15.1% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company’s stock valued at $2,194,000 after acquiring an additional 3,440 shares in the last quarter. Diversified Trust Co boosted its holdings in shares of Cooper Companies by 12.5% in the first quarter. Diversified Trust Co now owns 10,229 shares of the medical device company’s stock valued at $863,000 after acquiring an additional 1,135 shares in the last quarter. Finally, Bessemer Group Inc. increased its stake in shares of Cooper Companies by 1.8% during the first quarter. Bessemer Group Inc. now owns 1,830,561 shares of the medical device company’s stock valued at $154,408,000 after acquiring an additional 32,228 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Trading Up 0.3%

NASDAQ:COO opened at $73.02 on Thursday. The stock has a fifty day simple moving average of $75.97 and a 200 day simple moving average of $83.62. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The firm has a market capitalization of $14.60 billion, a price-to-earnings ratio of 35.45, a price-to-earnings-growth ratio of 1.78 and a beta of 0.99. The Cooper Companies, Inc. has a 1-year low of $65.00 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The business had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. During the same period last year, the firm posted $0.85 earnings per share. The firm’s quarterly revenue was up 6.3% compared to the same quarter last year. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have weighed in on COO. Stifel Nicolaus cut their target price on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research report on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a “hold” rating in a report on Thursday, March 13th. UBS Group raised Cooper Companies to a “buy” rating in a report on Tuesday, June 17th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. Finally, Loop Capital set a $100.00 price objective on shares of Cooper Companies in a research report on Tuesday, June 17th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, Cooper Companies has an average rating of “Moderate Buy” and a consensus price target of $99.70.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.